Liver Neoplasms study: Contrast-Enhanced Ultrasound vs Medical Chart Review
Official title Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
ClinicalTrials.gov ID: NCT06261814
What this study is testing
What is Sulfur Hexafluoride Lipid Microspheres?
This is an investigational imaging agent being studied to help doctors see liver tumors better during ultrasound scans. It is designed to reflect sound waves to make blood flow in the liver more visible on ultrasound images.
Also referred to as Lumason.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether contrast‑enhanced ultrasound can detect treatment response earlier than current imaging methods.
- Who it's for
- You may be able to join if you have liver tumors and are scheduled for transarterial chemoembolization.
- What's involved
- You will receive a special ultrasound during your treatment that uses a safe imaging agent to show blood flow. The test helps doctors see how the tumor is responding right away.
- Time commitment
- The study lasts only the day of your treatment; no extra visits are needed.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Scheduled for TACE therapy of a liver tumor
- Be at least 18 years of age
- Be medically stable
- If a female of child-bearing age, must have a negative pregnancy test
- Have signed informed consent to participate in the study
You likely can't join if
- Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable
- Patients with known sensitivities to the components of lumason
The study team makes the final eligibility decision.
Where it is enrolling
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.